Platform presentation at International Symposium on ALS/MND: “When Does ALS Begin? Insights from Serum and CSF Neurofilaments Light and Heavy”

Expanding on our previous work, we highlight the relative utility of NfL and pNfH as biomarkers of pre-symptomatic ALS, and hypothesize that the duration of the pre-symptomatic period varies based on genotype.